A recombinant human follicle-stimulating hormone (r-hFSH) used to stimulate ovarian follicular development in women undergoing assisted reproductive technologies or ovulation induction. It works by mimicking natural FSH, promoting the growth and maturation of ovarian follicles.

Indications:
- Treatment of anovulation in women who do not have primary ovarian failure.
- Ovulation induction in women with polycystic ovary syndrome (PCOS) or other ovulatory disorders.
- Controlled ovarian stimulation in assisted reproductive technologies (ART), including in vitro fertilization (IVF).
- Part of combination therapy with gonadotropin-releasing hormone (GnRH) analogues for follicular development.

Main Active Ingredient:
- Follitropin alfa (r-hFSH) 450 IU per 0.5 mL.

Precautions:
- Use only under supervision of a qualified fertility specialist.
- Not recommended in women with primary ovarian failure, uncontrolled thyroid or adrenal disorders, ovarian cysts, or hormone-sensitive tumors.
- Caution in patients with a history of ovarian hyperstimulation syndrome (OHSS) or multiple pregnancy.
- Monitor ovarian response via ultrasound and hormone levels to avoid excessive stimulation.
- Pregnant or breastfeeding women should not use the product.
- Store in a refrigerator (2-8°C) and protect from light; do not freeze.

Possible Side Effects:
- Ovarian hyperstimulation syndrome (OHSS).
- Abdominal pain.
- Bloating.
- Discomfort.
- Injection site reactions.
- Headache.
- Fatigue.
- Thromboembolic events.
- multiple pregnancies.
- Allergic reactions.

Drug-Drug Interactions:
- GnRH analogues.
- hCG (human chorionic gonadotropin).
- No significant interactions with common medications, but fertility drugs should always be managed under specialist supervision.